Precigen (PGEN) FY2017 results: revenue $219 million, up 14.9% on the year
Precigen, Inc. (PGEN) reported revenue of $219 million for fiscal 2017, the year ended 31 December 2017, up 14.9% on the year before. Net income was -$117 million, and diluted earnings per share $-0.98. The figures are the company's own, from the 10-K it filed with the SEC on 1 March 2018.
Revenue
$219 million
+14.9% on the year
FY2011FY2017
Operating margin
-62.8%
-65.6% a year earlier
FY2011FY2017
Net income
-$117 million
FY2011FY2017
Diluted EPS
-$0.98
FY2011FY2017
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2017
FY2016
FY2015
On the year
Last 8 years
Revenue
219
191
174
+14.9%
Cost of revenue
62.8
61.6
63.9
+1.9%
Gross profit
n/a
129
110
Gross margin
n/a
67.7%
63.2%
Research and development
143
112
147
+27.7%
Selling, general and administrative
146
142
109
+2.7%
Operating income
-138
-125
-147
Operating margin
-62.8%
-65.6%
-84.6%
Interest expense
0.6
0.9
1.2
-29.0%
Pre-tax income
-78.4
-194
-87.0
Income tax
2.1
-3.9
1.0
Net income
-117
-187
-84.5
Net margin
-53.3%
-97.7%
-48.7%
Diluted EPS
-$0.98
-$1.58
-$0.76
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2017
FY2016
FY2015
On the year
Last 8 years
Operating cash flow
-104
-49.0
35.7
Capital expenditure
46.7
31.6
12.7
+47.5%
Free cash flow
-150
-80.6
22.9
Free cash flow margin
-68.5%
-42.2%
13.2%
Cash from investing
104
-28.4
-259
Cash from financing
4.3
12.1
332
-64.5%
Depreciation and amortisation
31.1
24.6
17.7
+26.7%
Share-based compensation
41.6
42.2
38.7
-1.5%
Shares outstanding at period end
122m
119m
117m
+2.9%
Balance sheet
$ million
FY2017
FY2016
FY2015
On the year
Last 8 years
Shareholders' equity
534
560
694
-4.7%
Non-controlling interest
12.9
9.0
10.8
+43.3%
Debt
8.0
7.9
8.5
+1.1%
Other liabilities
292
372
269
-21.4%
Total liabilities and equity
847
949
982
-10.8%
Fixed assets
113
64.7
42.7
+74.2%
Goodwill
93.8
157
165
-40.4%
Intangible assets
233
226
248
+3.2%
Investments
6.3
181
208
-96.5%
Cash and equivalents
68.1
62.6
136
+8.8%
Receivables
19.8
21.6
25.1
-8.6%
Other assets
313
237
158
+32.4%
Total assets
847
949
982
-10.8%
10-K for the year ended 31 December 2017, filed 1 March 2018: the filing.